{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06078943",
            "orgStudyIdInfo": {
                "id": "DC-083185"
            },
            "organization": {
                "fullName": "Radiometer Medical ApS",
                "class": "INDUSTRY"
            },
            "briefTitle": "ABL90 FP MC Neonatal Arterial, Venous, Capillary Blood",
            "officialTitle": "ABL90 Flex Plus Method Comparison Neonatal Arterial, Venous, Capillary Blood",
            "therapeuticArea": [
                "Cardiovascular"
            ],
            "study": "fp-mc-neonatal-arterial-venous-capillary-blood"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-01-13",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-01-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-14",
            "studyFirstSubmitQcDate": "2023-10-09",
            "studyFirstPostDateStruct": {
                "date": "2023-10-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-09",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-12",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Radiometer Medical ApS",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The goal of this clinical trial is to validate performance claims for method comparison for ABL90 FLEX PLUS in heparinized neonatal arterial, venous, and capillary whole blood for ctBil and FHbF in a Point of Care (POC) setting.",
            "detailedDescription": "The main question it aims to answer is:\n\nTo quantify the relationship using comparison measurement from the same sample between the test device and the predicate device within the reportable range for ctBil and FHbF in heparinized arterial and venous neonatal whole blood in syringe measuring mode (S65, SP65) and heparinized mixed venous/arterial whole blood samples in capillary measuring mode (C65)."
        },
        "conditionsModule": {
            "conditions": [
                "Congenital Heart Disease"
            ],
            "keywords": [
                "Blood gas"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 612,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Investigational Device",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "The test device in this clinical study is the ABL90 FLEX PLUS running SW3.5 MR2 manufactured by Radiometer Medical ApS The analyzer provides results for 17 parameters in 35 seconds using 65 \u00b5L heparinized whole blood. However, in this investigation only the data concerning the parameters ctBil and FHbF will be evaluated.",
                    "interventionNames": [
                        "Device: method comparison"
                    ]
                },
                {
                    "label": "Predicate device",
                    "type": "SHAM_COMPARATOR",
                    "description": "The predicate device for this study is the unmodified device ABL90 FLEX PLUS (k160153) running software SW 3.1 MR7 including sensor casettes and solution packs versions corresponding to 2016.\n\nABL90 FLEX PLUS SW 3.1 MR7, has been selected as the predicate device because it has the appropriate 510(k) clearance, and the intended use matches the ABL90 FLEX PLUS SW. SW3.5 MR2 device.",
                    "interventionNames": [
                        "Device: method comparison"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "method comparison",
                    "description": "to quantify the relationship using comparison measurement from the same sample between ABL90 FLEX PLUS and the predicate device within the reportable range for all ctBil and FHbF in heparinized arterial and venous neonatal whole blood in syringe measuring mode (S65, SP65) and heparinized mixed venous/arterial whole blood samples in capillary measuring mode (C65)",
                    "armGroupLabels": [
                        "Investigational Device",
                        "Predicate device"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Slope, R^2 and bias",
                    "description": "Slope, R\\^2 and bias at medical decision points for each combination of modes and sample type",
                    "timeFrame": "6-9 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* The following are the inclusion criteria for the neonatal subjects:\n\n  * The age of the subject must be \u226428 days.\n  * Subject evaluated as suitable according to the protocol to enroll in the study by principal investigator or designee.\n  * Subjects having a sample drawn as part of standard of care that meets the requirements for samples in this study.\n\nThe following are the inclusion criteria for the subjects providing placenta for cord blood:\n\n\u2022 Delivery \u226538 weeks of gestation.\n\nExclusion Criteria:\n\n* The following are the exclusion criteria for the neonatal subjects:\n\n  * Subject who has already provided successful results from arterial, venous and mixed venous/arterial samples, to cover both syringe modes and the capillary mode and parameters.\n  * Subjects exposed to the substances listed in Appendix 1 with last dose within 72 hours, should be excluded due to risk of interference.\n  * Subjects with known infectious disease such as Hepatitis C and HIV (in order to ensure the operator safety).\n\nThe following are the exclusion criteria for the subjects providing placenta for cord blood:\n\n\u2022 Subjects positive of HIV or Hepatitis C",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "1 Day",
            "maximumAge": "28 Days",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Lone Pedersen, PhD",
                    "role": "CONTACT",
                    "phone": "+4528989640",
                    "email": "lone.graasboljuulpedersen@radiometer.dk"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Dennis Dietzen, PhD",
                    "affiliation": "St. Louis Children's Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "St Louis Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dennis Dietzen, PhD, DABCC, FAACC",
                            "role": "CONTACT",
                            "phone": "314-362-6586",
                            "email": "dietzen_d@wustl.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000006330",
                    "term": "Heart Defects, Congenital"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000018376",
                    "term": "Cardiovascular Abnormalities"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "asFound": "Heart Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9418",
                    "name": "Heart Defects, Congenital",
                    "asFound": "Congenital Heart Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M20503",
                    "name": "Cardiovascular Abnormalities",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}